LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS)

£29.00

+ Free Shipping
Category:

Letrozole 2.5 mg: UK Product Information and Treatment Overview

Letrozole 2.5 mg is an aromatase inhibitor used in specific hormone-sensitive breast cancer treatment plans. In the UK, it is a prescription-only medicine and should be used only when prescribed and monitored by an appropriate healthcare professional. Femara is a recognised brand containing letrozole, while several other authorised products are also available. The UK electronic Medicines Compendium confirms that each Femara tablet contains 2.5 mg of letrozole.

For people researching Buy LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS), it is important to understand that product information should be checked carefully before any treatment decision. The active ingredient reduces the body’s production of oestrogen by inhibiting aromatase, an enzyme involved in oestrogen formation. Lower oestrogen levels can help slow the growth of hormone-dependent breast cancer cells.

What Is Letrozole Used For?

The medicine is primarily indicated for postmenopausal women with hormone receptor-positive breast cancer. According to current UK product information, it may be used as adjuvant treatment for early invasive breast cancer, as extended adjuvant treatment after previous tamoxifen therapy, and for advanced disease in appropriate patients. Treatment selection depends on cancer characteristics, previous therapy, menopausal status and the individual’s overall clinical situation.

Because this is a prescription medicine, online product descriptions should not replace advice from an oncologist, doctor or pharmacist. Patients should confirm that the medicine, strength, manufacturer and pack details correspond with their prescription before use.

Strength and Pack Information

The stated presentation is 2.5 mg per tablet with 30 tablets in the pack. UK-authorised product information also lists 2.5 mg tablets in other pack sizes, depending on the manufacturer. Femara 2.5 mg tablets are supplied by Novartis Pharmaceuticals UK Ltd, while equivalent generic products are marketed by other authorised companies.

When comparing listings, check the active ingredient, strength, pharmaceutical form, manufacturer, expiry date and packaging. These details help distinguish a legitimate medicine from an inaccurately described or unsuitable product. A reliable pharmacy should provide clear information and appropriate prescription requirements.

How Treatment Is Normally Taken

The UK patient information states that the usual dose is one tablet once daily, although the exact treatment plan is determined by the prescribing clinician. Tablets may generally be taken with or without food and should be swallowed with water. Patients should follow the instructions on their prescription rather than changing the dose, timing or duration independently. (Medicines.org.uk)

If a dose is missed, patients should follow the instructions in the official leaflet or contact a pharmacist for advice. Taking extra tablets to compensate for a missed dose is not recommended unless specifically instructed by a healthcare professional.

Important Safety Information

Letrozole is not suitable for everyone. The UK patient leaflet advises that it should not be taken by people who are pregnant or breastfeeding, and it is generally intended for women who have gone through menopause. Patients should tell their clinician about severe kidney or liver disease, a history of osteoporosis or bone fractures, allergies, and all other medicines or supplements they use.

The treatment can reduce oestrogen and may affect bone health. Healthcare professionals may therefore monitor bone density and assess fracture risk during therapy. Some patients experience joint or muscle discomfort, hot flushes, fatigue, dizziness or other adverse effects. Tendon problems can also occur. Any severe, persistent or unusual symptom should be discussed promptly with a doctor or pharmacist.

Interactions and Professional Monitoring

Before starting therapy, patients should provide a complete list of prescription medicines, over-the-counter products and supplements. Certain medicines can affect treatment, so professional review is important. Regular follow-up allows the healthcare team to assess response, manage adverse effects and determine whether continuing therapy remains appropriate.

Why Choose Clear UK Product Information?

A well-structured product page should provide accurate, transparent information rather than unsupported claims. Visitors should be able to identify the active ingredient, dosage strength, pack size, intended medical use and prescription status without confusion. Clear descriptions also help users distinguish approved medicines from products with uncertain origin or incomplete labelling.

For UK audiences, trustworthy information is especially important because prescription medicines should be obtained through legitimate healthcare channels. The Electronic Medicines Compendium provides current product leaflets and professional information for Femara and other authorised letrozole products. Checking these resources can help patients understand warnings, ingredients, administration instructions and possible adverse effects.

Final Considerations

Buy LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS) may be used as a search phrase for a product page, but responsible content should make clear that this medicine requires professional oversight. Letrozole is a clinically established aromatase inhibitor with specific indications in hormone-dependent breast cancer. Its benefits and risks vary between individuals, so treatment should always be based on a valid prescription and medical assessment.

Before using any 2.5 mg tablet, verify the label, packaging, expiry information and source. Never share prescription medicines with another person, and do not alter treatment without medical advice. If you have questions about suitability, interactions, side effects or ongoing treatment, speak with your doctor, oncology team or pharmacist. Use authorised UK pharmacies and follow current prescribing guidance from healthcare team.

LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS)LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS)

Reviews

There are no reviews yet.

Be the first to review “LETROZOLE 25 (FEMARA) (2,5 MG/TAB. – 30 TABS)”

Your email address will not be published. Required fields are marked *

Shopping Cart